APMD 株価分析 — Apnimed, Inc. Common Stock (Healthcare >> Biotechnology)
APMD に関するよくある質問
APMDのPER(株価収益率)は?
Apnimed, Inc. Common Stock(APMD)は現在PER 14.15倍で取引されています。
APMDのROE(自己資本利益率)は?
Apnimed, Inc. Common StockのROEは16.20%です。
APMDの配当利回りは?
Apnimed, Inc. Common Stockの配当利回りは0.00%です。
APMDの品質スコア(Quality Score)は?
当社のAIはAPMDの総合財務品質を100点中69点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
APMDは今が買い時ですか?
当社AIのタイミングスコアは100点中1点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
APMDはどのセクターに属しますか?
Apnimed, Inc. Common StockはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)
APMD AI Analysis Summary
Our AI summary for APMD: Apnimed, Inc. Common Stock (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 14.15, ROE of 16.20%, a dividend yield of 0.00%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 1/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 26.51
Price
0.80
(3.11%)
Day Change
|
|
|---|
APMD, ファンダメンタルスコアはok ( ファンダメンタル = 69) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
昨年度のROEが一昨年比で低い
ROAの伸びが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 95 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 26.51 |
| PBV / Sector |
3.86 / 44,105.10
|
| Earning Per Share | 1.11 |
| PE / Sector |
14.15 / 19.37
|
| PEG or PE/Growth / Sector |
N/A / 1.06
|
| Average 1M Daily Value |
30.95 M
GREAT
|
| Average 1W Daily Value |
30.95 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-08-06 07:59:38 |
| Symbol | APMD |
| Name | APNIMED, INC. COMMON STOCK |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 39.82 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 995.58 / 9,702.21 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 39 John F. Kennedy Street, Cambridge, MA, United States, 02138
Phone: (617) 500-8880
Website: https://apnimed.com
Employees: 65
Sector: Healthcare >> Biotechnology
Description: Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google